Skip to content

Lifeline Unipolar Lead #487-05

by Intermedics, Inc. 510(k)

Active United States

510(k) K823508

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK823508 Date14 Jan 1983ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Lifeline Unipolar Lead #487-05 is a Permanent Pacemaker Electrode, designed for implantation in the cardiovascular system to provide electrical stimulation for pacing purposes. This device delivers unipolar pacing signals to regulate abnormal heart rhythms, ensuring consistent cardiac function in patients requiring chronic pacing therapy.

This lead is supplied sterile and intended for single-use implantation by qualified healthcare professionals in clinical settings such as hospitals or cardiac care units. It is classified as a Class III medical device under FDA regulations and has received FDA 510K clearance as substantially equivalent to a predicate device. The lead adheres to regulatory standards outlined in 21 CFR 870.3680 and is distributed with detailed surgical instructions for proper placement within the heart.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Lifeline Unipolar Lead #487-05 and how does it function in the body?

    The Lifeline Unipolar Lead #487-05 is designed as a permanent pacemaker electrode for implantation in the cardiovascular system. It delivers unipolar pacing signals to regulate abnormal heart rhythms, ensuring consistent cardiac function in patients who require chronic pacing therapy. By stimulating the heart electrically, it helps maintain proper heart rate and rhythm for those with conditions like bradycardia or other arrhythmias.

  • Is this device intended for reuse or single-use, and what are the implications for clinical settings?

    The Lifeline Unipolar Lead #487-05 is sterile and intended for single-use only. This means it is meant to be implanted once by qualified healthcare professionals in controlled environments like hospitals or cardiac care units. Single-use design ensures patient safety by minimizing infection risks associated with reuse, though it also requires proper inventory management to account for each procedure.

  • What regulatory pathway was followed for FDA clearance of this device, and which committee was involved?

    The Lifeline Unipolar Lead #487-05 received FDA 510K clearance under the Traditional Review pathway, determined to be substantially equivalent (SESE) to a predicate device. The Cardiovascular (CV) Advisory Committee was involved in reviewing its safety and effectiveness, aligning with its classification as a Class III medical device under 21 CFR 870.3680. This process ensures compliance with rigorous standards for pacemaker electrodes.

  • Does this lead come with specific instructions for proper surgical placement, and what should clinicians consider during implantation?

    Yes, the Lifeline Unipolar Lead #487-05 is distributed with detailed surgical instructions to guide proper placement within the heart. Clinicians should follow these instructions closely to ensure accurate positioning for effective pacing. Since it is designed for permanent implantation, factors like lead stability, electrode contact with cardiac tissue, and avoidance of phrenic nerve stimulation must be carefully managed during the procedure.